Florokinolon Grubu Antibiyotikleri
Bu derlemede İnsan hekimliğinden ve Veteriner Hekimlikte kullanılan yeni
kuşak Kinolon grubu ilaçlardan Florokinolon grubu antibiyotikler, etki
mekanizmaları , kimyasal yapıları , antibakteriyel spektrumları ,
fannakokinetikleri, klinik kullanımları , dirençlilik ve yan etkileri incelenmiştir.
Kinolonların yapılarına Flor atomu ve Piperazin grubunun eklenmesiyle
antimikrobiyel kemoterapide büyük ilerleme oluşmuştur. Bunların başlıcaları
Nortfloksasin, Otloksasin, Petloksasin, Siprotloksasin, Enoksasin, Difloksasin,
Danofloksasin, Fleroksasindir. Bakterisit etkili olup, replikasyon, rekombinasyon
ve transkripsiyon olaylarında önemli olan bakteriyel DNAjiraz enzimini inhibe
ederek DNA sentezini önlediği kabul edilmektedir. Florokinolonların etkisiyle
bakteriler bölünmez ve anormal şekilde uzayarak ölürler.
Florokinolonlar güçlü bakterisit etkilidirler, yan etki olasılıkları zayıf ve
bakteriyel dirençlilik olguları seyrektir. Etki spekturumları geniştir. Gram ( -)
aerobik patojenlerin çağuna karşı iyi bir şekilde etkili olup, Gram (+)
mikroorganizmalar ve mikrobacteri türlerine karşı da etkili oldukları
görülmektedir.
The antibiotics in the tluorokinolon group
In this review. the modes of effcct, chemical stnıctures. antibacterial
spectnıms , pharınacokinetics , elinical usage, resistances and side effccts of the
antibiotics in the in the tluorkinolon group. a new gencration of kinolon group
dnıgs used in human and veterinary medicine was studied. There has been a
great improvemcnt in antimicrobial chemotherapy by the addition of tl u or atom
and piperazine group to the stnıcture of the kinolons. Norfloxacin, Otloxacin,
Pefloxacin, Cyprofloxacin, Enoxacin, Difloxacin, Danofloxacin, Fleroxacin are
principal representators of this group. They have bactericid effect and they are
regarded as to prevent the DNA synthesis by the inhibition of bacterial DNA girase enzyme which has an important rol in the replication, recombination and
transcriptian activities. By the effect of the fluorokinolons, the bacteria do not
divide and they elongate abnormally and die.
The fluorokinolons have strong bactericid cffect, their side effect
probabailities are weak and the cascs of bactcrial resistance are rare. Their
spectnıms are \vide. They have been found to be quite effective to most of the
Gram (-) aerobic pathogens and effective to Gram (+) microorganlsms and
mycobacterium species.
___
- BALL, P. (1989): Adverse reactions and interactions of fluoroquinolones.
Clinical and investigative medicine Vol. 12( 1 ): 28-34.
- BELLİDO, F. and PECHERE J.C (1989) : Laboratory Survey of
Fluoroquinolone Activity. Reviews of infectios discases Vol. I 1(5) : 917-924.
- BÜRKSHARDT, J.E., HİLL M.A. CARLTON, W.M., and
KEST-ERSON J.W. (1990) : Histologic and Histo Chemical Changes in
Articular Cartilages of immature Beale dogs doscd with Difloxacin,
Fluoroquinolone. Vet. Pathol. 27 : (162- I 70).
- CASTORA, J.F., VİSSERİNG, F.F, and SİMPSON, V.M., (l983) :
The effect of bacterial DNA gyrase inhibitors on DNA sunthesis in mammalian
mitochondria Biochemica et Biophysica Acta. 740: (417-427) .
- CHU, D.T.W. and FERNANDES, P.B. (1989) : Structure-Activity
Relationships of the Fluoroquinolones. Antimicrobial agents and Chemotherapy
Vol. 33(2): 131-135 .
- DOĞAN, A., BİLGİLİ, A. ve DAĞOĞLU, G. (1991) : Veteriner
Hekimlikte kullanıma yeni giren antibakteriyel ilaçlar: Kinolonlar. Y.Y.Ü. Vet.
Fak. Derg. 2(~-2): 141-151.
- DOUİDAR, M. S. and SNODGRASS, W.R, (I 989) : Potential Role of
Floroquinolones in Rediatric ınfections'. Reviews of infections disease. Vol : 11-
6.
- FERNANDES, P.B. ( 1988) : Mode of action, and invitro and invivo
activities of fluoroquinolones. J.Clin Parmacol. 28: 156-168.
- GİLES, C.J. GRiMSHAW, W.T.R, SHANKS, D.J., SMiTH, D.G.
(1991) : Kapalı Ahırlarda yetiştirilen besi sığırlarında akut bakteriyel pnömoni
vakalarının tedavisinde danofloxacinnin etkinliği . Veterinary Record 128: 296-
300.
- HOOPER, C. D., and WOLFSON S.J.( 1989) : Treatment of
Genitourinary Tract infections with Fluoroquinolones. Clinical Efficacy in Ganital
infections and Adverse Effects. Antimicrobial agents and Chemotherapy. Vol:
33 (10): 1662-1667.
- HOOPER, D. C, WOLFSON-J.S. (1985) :The Fluoroquinolones:
Pharmacology, Clinical uses, and Toxicities in Humans . Antimicrobial agents
and chemotherapy. Vol. 28 (5) : 761-721.
- JAMES, D.G., ( 1989) : The Fluoroquinolones, Therapeutic Focus.
The British Journal of Clinical Practice. 43 (2).
- MONTAY, G. and GAİLLOT, J. (1990): Pharmocokinetics of
Fluoroquinolones in hepatic failure. Journal of Antimicrobial Chemotherapy.
26.
- MURRAY, B. E. ( 1989) : lmpact of Fluoroquinolones on the Gastro
intestinal Flora, Reviews of infekrtions diseases Vol. ll.
- NEER, T.M. (1988): Clinical pharmacologic features of fluoroquinolone
antimicrobial drugs JAVMA Vol. 193 (5).
- NEA, H.C. (1987) : New Antibiotics. Areas of Apprapriate use. The
journal of infections diseases. Vol. 155 (3): 403-415.
- NEU, H.C. ( 1989): Synergy of fluoroquinolones with other antimicrobial
agents. Reviews of infections disease. Vol. 11 (5).
- NEUMA N, M. (I 988) : Clinical Pharmacokinetics of the Newer
antibacteriyel 4-quinolones. Clinical Pharmacokinetis . Vol: I 4:96- I 2 I
- NOUWS, J.F.M., NEVİNS, D.J., UREA, T.B, BAARS, A.M., and
J. LAURENSEN. ( 1988): Pharmacokinctics, renal elearance and Metabolism
of cipnotloxacin following intravenous and oral administration to calves and
pigs. The veterinary quartcrey Vol. 10 (3).
- OATES, J.A, WOOD, A.J.J. (199 I): Fluoroquinolone antimicrobial
agents. The New England Journal of Medicine Vol. 324 (6).
- PATON, J.H, and REEVES, D.S. ( 1988): Fluoroquinolone Antibiotics.
Microbology. Pharnıacokinetiks and Clinical use. Dnıgs . 36: (193-228).